Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 18Breast 14Tumor-Agnostic 13Other hematologic neoplasm 12Gynecologic 12Genitourinary 11Lymphoid 8Thoracic 7Head & Neck 7Sarcoma 4Plasma cell 4Other solid neoplasm 4Other 3Dermatologic 3CNS 3Other neoplasm 2Myeloid 1Classical hematology 1

Conditions

Neoplasms 1Anemia, Sickle Cell 1

Interventions

fludarabine phosphate 58Cyclophosphamide 54Epoetin Alfa 43Cyclosporine 42Busulfan 42Peripheral Blood Stem Cell Transplantation 38Mycophenolic Acid 33Darbepoetin alfa 33Antilymphocyte Serum 31Cytarabine 30Whole-Body Irradiation 29Filgrastim 29Methotrexate 26Tacrolimus 25Radiotherapy 25Melphalan 24fludarabine 21Methylprednisolone 17Cord Blood Stem Cell Transplantation 17Granulocyte Colony-Stimulating Factor 13Etoposide 13Daunorubicin 13Rivaroxaban 12apixaban 11Thiotepa 11sargramostim 10epoetin beta 10Dalteparin 10eltrombopag 9Alemtuzumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Interviews as Topic × Classical hematology × Clear all
NCT01591187 2015-03-05

The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease

St. Jude Children's Research Hospital

Completed
77 enrolled
Classical hematology

Anemia, Sickle Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡